Joel Ramirez

Dr. Joel Ramirez


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
KHKaren Ho
Karen Ho
JRJoel Ramirez
Joel Ramirez
RKRohan Nevin Kulkarni
Rohan Nevin Kulkarni
KHKatharine G. Harris
Katharine G. Harris
IHIrene Helenowski
Irene Helenowski
SGS. Marlene Grenon
S. Marlene Grenon
Cardiovascular diseases are associated with gut dysbiosis, but the role of microbe-derived metabolites as biomarkers or modulators of cardiovascular disease are not well understood. This is a targeted metabolomics study to investigate the association of nine microbe-derived metabolites with lower extremity peripheral artery disease (PAD), a form of atherosclerosis, and major adverse cardiac events (MACE). The study cohort consists of individuals with intermittent claudication and ankle-brachial index (ABI) < 0.9 (N = 119) and controls without clinically-apparent atherosclerosis (N = 37). The primary endpoint was MACE, a composite endpoint of myocardial infarction, coronary revascularization, stroke, transient ischemic attack, or cardiac-related death. Plasma metabolite concentrations differed significantly between the PAD and control groups. After adjustment for traditional atherosclerosis risk factors, kynurenine, hippuric acid, indole-3-propionic acid (IPA), and indole-3-aldehyde (I3A) concentrations were negatively associated with PAD, whereas indoxyl sulfate and 3-hydroxyanthranilic acid were positively associated. Hippuric acid, IPA, and I3A correlated with ABI, a surrogate for atherosclerotic disease burden. Those in the highest I3A concentration quartile had significantly improved freedom from MACE during follow-up compared to those in the lowest quartile. This study identifies specific indole- and phenyl-derived species impacted by gut microbial metabolic pathways that could represent novel microbiome-related biomarkers of PAD.

18 March 2019 in Lipids
Verified
Journal Article
Closed access
PDF file
JRJoel Ramirez
Joel Ramirez
GZGreg J. Zahner
Greg J. Zahner
KSKimberly A. Spaulding
Kimberly A. Spaulding
SKSukaynah A. Khetani
Sukaynah A. Khetani
NHNancy K. Hills
Nancy K. Hills
SGS. Marlene Grenon
S. Marlene Grenon

18 September 2018 in CVIR Endovascular
Verified
Journal Article
Open access
PDF file
JRJoel Ramirez
Joel Ramirez
SGS. Marlene Grenon
S. Marlene Grenon

1 August 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
JRJoel Ramirez
Joel Ramirez
DZDevin S. Zarkowsky
Devin S. Zarkowsky
JMJahan Mohebali
Jahan Mohebali
MNMark R. Nehler
Mark R. Nehler
JLJose Lopez
Jose Lopez
MSMatthew R. Smeds
Matthew R. Smeds

11 June 2022 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
JRJoel Ramirez
Joel Ramirez
MNMark R. Nehler
Mark R. Nehler
JMJahan Mohebali
Jahan Mohebali
ESEric J.T. Smith
Eric J.T. Smith
MAMohammad H. Al-Musawi
Mohammad H. Al-Musawi
DZDevin S. Zarkowsky
Devin S. Zarkowsky